In a mouse model, transgenic expression of LMP1 in B cells was sufficient to develop lymphoma that resembled human DLBCL under immunosuppression, which mimics EBV+ DLBCL [9]. Here, PDLIM7 is linked to diffuse large B-cell lymphoma.